| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK18 MAK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 TAOK1 PRKDC MAPK1 MAPK11 MAP4K4 | 1.15e-08 | 363 | 147 | 16 | GO:0106310 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 PRKDC MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 1.77e-08 | 600 | 147 | 20 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 TAOK1 PRKDC MAPK1 MAPK11 MAP4K4 | 3.32e-08 | 446 | 147 | 17 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 PRKDC MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 2.66e-07 | 709 | 147 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 PRKDC MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 8.59e-07 | 764 | 147 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK18 MAK MYLK POLR2A GNPTAB PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 PRKDC MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 1.45e-06 | 938 | 147 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | MAP kinase activity | 4.79e-06 | 16 | 147 | 4 | GO:0004707 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 5.38e-05 | 2 | 147 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | monoacylglycerol lipase activity | 2.04e-04 | 16 | 147 | 3 | GO:0047372 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 5.31e-04 | 5 | 147 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 5.31e-04 | 5 | 147 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | lipase activity | 5.56e-04 | 138 | 147 | 6 | GO:0016298 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 6.96e-04 | 144 | 147 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid acyltransferase activity | 7.06e-04 | 24 | 147 | 3 | GO:0042171 | |
| GeneOntologyMolecularFunction | lysophospholipid acyltransferase activity | 7.06e-04 | 24 | 147 | 3 | GO:0071617 | |
| GeneOntologyMolecularFunction | acetylesterase activity | 7.92e-04 | 6 | 147 | 2 | GO:0008126 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 9.37e-04 | 59 | 147 | 4 | GO:0008374 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 9.91e-04 | 103 | 147 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 1.09e-03 | 157 | 147 | 6 | GO:0052689 | |
| GeneOntologyMolecularFunction | short-chain carboxylesterase activity | 1.10e-03 | 7 | 147 | 2 | GO:0034338 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.10e-03 | 7 | 147 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | phospholipase activity | 1.56e-03 | 114 | 147 | 5 | GO:0004620 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 1.66e-03 | 32 | 147 | 3 | GO:0016411 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.69e-03 | 171 | 147 | 6 | GO:0015081 | |
| GeneOntologyBiologicalProcess | cellular response to UV-B | 1.11e-06 | 12 | 145 | 4 | GO:0071493 | |
| GeneOntologyBiologicalProcess | stress-activated MAPK cascade | 4.39e-06 | 61 | 145 | 6 | GO:0051403 | |
| GeneOntologyBiologicalProcess | stress-activated protein kinase signaling cascade | 9.06e-06 | 69 | 145 | 6 | GO:0031098 | |
| GeneOntologyBiologicalProcess | response to UV-B | 1.28e-05 | 21 | 145 | 4 | GO:0010224 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PLOD3 ZFYVE27 NCKAP1 DOCK10 PAK6 TAOK2 IL1RAPL1 STK11 CRYGB MAPK14 CELSR3 TET1 LHFPL5 KDR UNC93B1 PRKDC MAP4K4 HCK ZMYM4 CNTN2 CNTN1 EPHA3 | 3.13e-05 | 1194 | 145 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.47e-05 | 228 | 145 | 9 | GO:0046777 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | CACUL1 SASH1 PSEN2 GAS6 FBXO11 KEAP1 FASLG TESK1 AXIN2 TAOK2 PASK STK11 AKTIP LRRN3 MAPK12 APH1A SECISBP2 FNIP1 KDR TAOK1 PRKDC MAPK1 CNTN2 CNTN1 | 7.95e-05 | 1458 | 145 | 24 | GO:0051247 |
| GeneOntologyCellularComponent | endosome | ZFYVE27 PSEN2 AVPR1A HAP1 VPS13C ATP13A5 ATP9B ABHD17C GPR161 NEURL3 AP1B1 APH1A NISCH MTM1 STOML1 ASTN1 ASTN2 KDR UNC93B1 MAPK1 DAGLA EPHA3 | 1.61e-05 | 1167 | 144 | 22 | GO:0005768 |
| Domain | Protein_kinase_ATP_BS | CDK18 MAK MYLK PAK4 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 9.08e-10 | 379 | 145 | 18 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 2.92e-09 | 459 | 145 | 19 | PS00107 |
| Domain | Kinase-like_dom | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 PRKDC MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 7.66e-09 | 542 | 145 | 20 | IPR011009 |
| Domain | Prot_kinase_dom | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 8.20e-09 | 489 | 145 | 19 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 KDR TAOK1 MAPK1 MAPK11 MAP4K4 HCK EPHA3 | 9.35e-09 | 493 | 145 | 19 | PS50011 |
| Domain | Ser/Thr_kinase_AS | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TAOK2 PASK STK11 MAPK14 MAPK12 TAOK1 MAPK1 MAPK11 MAP4K4 | 1.24e-07 | 357 | 145 | 15 | IPR008271 |
| Domain | S_TKc | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TAOK2 PASK STK11 MAPK14 MAPK12 TAOK1 MAPK1 MAPK11 MAP4K4 | 1.34e-07 | 359 | 145 | 15 | SM00220 |
| Domain | PROTEIN_KINASE_ST | CDK18 MAK MYLK PAK4 MAP3K20 PAK6 TAOK2 PASK STK11 MAPK14 MAPK12 TAOK1 MAPK1 MAPK11 MAP4K4 | 1.49e-07 | 362 | 145 | 15 | PS00108 |
| Domain | Pkinase | CDK18 MAK MYLK PAK4 PAK6 TESK1 TAOK2 PASK STK11 MAPK14 MAPK12 TAOK1 MAPK1 MAPK11 MAP4K4 | 2.87e-07 | 381 | 145 | 15 | PF00069 |
| Domain | MAPK | 1.64e-06 | 12 | 145 | 4 | PS01351 | |
| Domain | MAP_kinase_CS | 1.64e-06 | 12 | 145 | 4 | IPR003527 | |
| Domain | MAPK_p38 | 1.82e-06 | 4 | 145 | 3 | IPR008352 | |
| Domain | Glyco_hydro_31 | 1.57e-05 | 7 | 145 | 3 | IPR000322 | |
| Domain | Glyco_hydro_31 | 1.57e-05 | 7 | 145 | 3 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.57e-05 | 7 | 145 | 3 | PS00129 | |
| Domain | Astrotactin | 5.99e-05 | 2 | 145 | 2 | IPR026995 | |
| Domain | FN3 | 9.99e-05 | 185 | 145 | 8 | SM00060 | |
| Domain | FN3 | 1.65e-04 | 199 | 145 | 8 | PS50853 | |
| Domain | FN3_dom | 2.31e-04 | 209 | 145 | 8 | IPR003961 | |
| Domain | Gal_mutarotase_N | 3.56e-04 | 4 | 145 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 3.56e-04 | 4 | 145 | 2 | PF16863 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 5.89e-04 | 5 | 145 | 2 | PS00707 | |
| Domain | DUF3504 | 5.89e-04 | 5 | 145 | 2 | IPR021893 | |
| Domain | K/Na/Ca-exchanger | 5.89e-04 | 5 | 145 | 2 | IPR004481 | |
| Domain | DUF3504 | 5.89e-04 | 5 | 145 | 2 | PF12012 | |
| Domain | Glycoside_hydrolase_SF | 7.60e-04 | 53 | 145 | 4 | IPR017853 | |
| Domain | Glyco_hydro_31_AS | 8.80e-04 | 6 | 145 | 2 | IPR030458 | |
| Domain | WASP_C | 1.23e-03 | 7 | 145 | 2 | IPR011026 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 6.67e-08 | 6 | 117 | 4 | M47766 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 3.66e-06 | 29 | 117 | 5 | M39676 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS | 2.94e-05 | 22 | 117 | 4 | M39902 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING | 3.53e-05 | 23 | 117 | 4 | M39709 | |
| Pathway | WP_MAPK_SIGNALING | MAP3K20 FASLG TAOK2 CACNA2D4 MAPK14 MAPK12 TAOK1 MAPK1 MAPK11 MAP4K4 | 3.79e-05 | 246 | 117 | 10 | M39597 |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 4.20e-05 | 47 | 117 | 5 | M39518 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 5.53e-05 | 160 | 117 | 8 | MM15990 | |
| Pathway | PID_P38_MKK3_6PATHWAY | 5.85e-05 | 26 | 117 | 4 | M20 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 5.85e-05 | 26 | 117 | 4 | M47565 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 6.22e-05 | 120 | 117 | 7 | MM14585 | |
| Pathway | REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION | 6.41e-05 | 10 | 117 | 3 | M27146 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 6.41e-05 | 10 | 117 | 3 | MM15135 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 6.41e-05 | 10 | 117 | 3 | M13962 | |
| Pathway | WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION | 6.82e-05 | 27 | 117 | 4 | M39838 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | MAP3K20 FASLG TAOK2 CACNA2D4 MAPK14 MAPK12 TAOK1 MAPK1 MAPK11 MAP4K4 | 7.55e-05 | 267 | 117 | 10 | M10792 |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 7.91e-05 | 28 | 117 | 4 | M39572 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 9.36e-05 | 128 | 117 | 7 | M706 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.50e-04 | 13 | 117 | 3 | M1441 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 1.72e-04 | 34 | 117 | 4 | M13881 | |
| Pathway | SIG_CD40PATHWAYMAP | 1.72e-04 | 34 | 117 | 4 | M12705 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 2.16e-04 | 36 | 117 | 4 | M39908 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 2.26e-04 | 196 | 117 | 8 | MM14591 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 2.41e-04 | 37 | 117 | 4 | MM14899 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 2.76e-04 | 108 | 117 | 6 | M9904 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 3.72e-04 | 211 | 117 | 8 | M649 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 4.18e-04 | 76 | 117 | 5 | M1749 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 4.18e-04 | 76 | 117 | 5 | MM1433 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 4.71e-04 | 78 | 117 | 5 | M39824 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 4.74e-04 | 44 | 117 | 4 | M13720 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 4.90e-04 | 19 | 117 | 3 | MM14780 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 5.60e-04 | 81 | 117 | 5 | M13863 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 5.73e-04 | 20 | 117 | 3 | M14339 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 5.73e-04 | 20 | 117 | 3 | M12256 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 7.65e-04 | 22 | 117 | 3 | M13408 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 7.65e-04 | 22 | 117 | 3 | MM1449 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 7.65e-04 | 22 | 117 | 3 | M27210 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING | 8.34e-04 | 51 | 117 | 4 | M39438 | |
| Pathway | WP_LDL_INFLUENCE_ON_CD14_AND_TLR4 | 8.74e-04 | 23 | 117 | 3 | M45556 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 9.93e-04 | 24 | 117 | 3 | M27553 | |
| Pathway | REACTOME_MYOGENESIS | 9.93e-04 | 24 | 117 | 3 | MM15174 | |
| Pathway | WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART | 9.93e-04 | 24 | 117 | 3 | M39576 | |
| Pathway | WP_ANGIOGENESIS | 9.93e-04 | 24 | 117 | 3 | M39556 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.12e-03 | 25 | 117 | 3 | MM15269 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.12e-03 | 25 | 117 | 3 | M274 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 1.26e-03 | 26 | 117 | 3 | MM14716 | |
| Pathway | WP_PARKINSONS_DISEASE | 1.27e-03 | 57 | 117 | 4 | MM15899 | |
| Pubmed | Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN. | 2.12e-08 | 8 | 147 | 4 | 12761180 | |
| Pubmed | 4.29e-08 | 78 | 147 | 7 | 17192257 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 22522454 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 18256287 | ||
| Pubmed | The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. | 2.13e-07 | 13 | 147 | 4 | 17906618 | |
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 20610565 | ||
| Pubmed | Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. | 2.95e-07 | 4 | 147 | 3 | 18177852 | |
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 19936205 | ||
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 10066767 | ||
| Pubmed | 2.97e-07 | 14 | 147 | 4 | 12239168 | ||
| Pubmed | PRAK, a novel protein kinase regulated by the p38 MAP kinase. | 4.03e-07 | 15 | 147 | 4 | 9628874 | |
| Pubmed | SASH1 VPS13C PAK4 KEAP1 TAOK2 PASK CELSR3 DDHD1 TET1 ARHGAP20 MAP4K4 DAGLA ZMYM4 | 4.39e-07 | 529 | 147 | 13 | 14621295 | |
| Pubmed | SOX10 SETD1B MYLK TOR2A POLR2A PAK4 KEAP1 MAPK14 MAPK12 AP1B1 MTM1 MAPK1 MAPK11 USP15 HCK | 5.36e-07 | 730 | 147 | 15 | 34857952 | |
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 13679851 | ||
| Pubmed | ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome. | 7.35e-07 | 5 | 147 | 3 | 35857590 | |
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 15632108 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 17304211 | ||
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 1.41e-06 | 20 | 147 | 4 | 32662771 | |
| Pubmed | Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice. | 1.47e-06 | 6 | 147 | 3 | 27856911 | |
| Pubmed | 1.47e-06 | 6 | 147 | 3 | 14680475 | ||
| Pubmed | 2.11e-06 | 22 | 147 | 4 | 16751104 | ||
| Pubmed | p38 MAPK signalling cascades: ancient roles and new functions. | 2.56e-06 | 7 | 147 | 3 | 10878576 | |
| Pubmed | F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2. | 4.08e-06 | 8 | 147 | 3 | 34703820 | |
| Pubmed | 4.08e-06 | 8 | 147 | 3 | 37885410 | ||
| Pubmed | Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. | 4.08e-06 | 8 | 147 | 3 | 9155017 | |
| Pubmed | 4.40e-06 | 371 | 147 | 10 | 25241761 | ||
| Pubmed | Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality. | 4.98e-06 | 27 | 147 | 4 | 28542142 | |
| Pubmed | Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2. | 6.10e-06 | 9 | 147 | 3 | 11279118 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PLOD3 MYLK NCKAP1 PAK4 GAS6 MAP3K20 AXIN2 STK11 MAPK14 AP1B1 NUP133 MAPK1 MAPK11 MAP4K4 HCK | 7.87e-06 | 910 | 147 | 15 | 36736316 |
| Pubmed | 8.69e-06 | 10 | 147 | 3 | 12223406 | ||
| Pubmed | Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. | 8.69e-06 | 10 | 147 | 3 | 9199504 | |
| Pubmed | 8.69e-06 | 10 | 147 | 3 | 14985505 | ||
| Pubmed | Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. | 1.19e-05 | 11 | 147 | 3 | 23742646 | |
| Pubmed | 1.58e-05 | 12 | 147 | 3 | 12171600 | ||
| Pubmed | MAP4K4 is involved in the neuronal development of retinal photoreceptors. | 1.58e-05 | 12 | 147 | 3 | 37290629 | |
| Pubmed | Fasting-induced activation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus. | 1.77e-05 | 2 | 147 | 2 | 14763996 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 16177070 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 14724572 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26418326 | ||
| Pubmed | The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell. | 1.77e-05 | 2 | 147 | 2 | 15824134 | |
| Pubmed | p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. | 1.77e-05 | 2 | 147 | 2 | 19251701 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 27486885 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24531379 | ||
| Pubmed | p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart. | 1.77e-05 | 2 | 147 | 2 | 32573492 | |
| Pubmed | Effect of p38 MAP kinases on contractility and ischemic injury in intact heart. | 1.77e-05 | 2 | 147 | 2 | 19706373 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 30103804 | ||
| Pubmed | STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive? | 1.77e-05 | 2 | 147 | 2 | 34500370 | |
| Pubmed | Involvement of p38 MAPK in Leydig cell aging and age-related decline in testosterone. | 1.77e-05 | 2 | 147 | 2 | 36950685 | |
| Pubmed | Differential Involvement of ERK2 and p38 in platelet adhesion to collagen. | 1.77e-05 | 2 | 147 | 2 | 15851480 | |
| Pubmed | Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review. | 1.77e-05 | 2 | 147 | 2 | 30489659 | |
| Pubmed | Counter-regulation of T cell effector function by differentially activated p38. | 1.77e-05 | 2 | 147 | 2 | 24863062 | |
| Pubmed | BPTF Maintains Chromatin Accessibility and the Self-Renewal Capacity of Mammary Gland Stem Cells. | 1.77e-05 | 2 | 147 | 2 | 28579392 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 34648772 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17724032 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 27605380 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20188737 | ||
| Pubmed | SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. | 1.77e-05 | 2 | 147 | 2 | 8925912 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 29767236 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28830982 | ||
| Pubmed | Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. | 1.77e-05 | 2 | 147 | 2 | 23282009 | |
| Pubmed | Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation. | 1.77e-05 | 2 | 147 | 2 | 29357353 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 30696770 | ||
| Pubmed | HIV-1 activates macrophages independent of Toll-like receptors. | 1.77e-05 | 2 | 147 | 2 | 19048100 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18957688 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20190562 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 31513357 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25497973 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25831013 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 8598454 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18162457 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 35753125 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17105766 | ||
| Pubmed | Active mutants of the human p38alpha mitogen-activated protein kinase. | 1.77e-05 | 2 | 147 | 2 | 15284239 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21865449 | ||
| Pubmed | HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation. | 1.77e-05 | 2 | 147 | 2 | 15928037 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 16476765 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17241234 | ||
| Pubmed | Exploring the dynamics of adult Axin2 cell lineage integration into dentate gyrus granule neurons. | 1.77e-05 | 2 | 147 | 2 | 38449734 | |
| Pubmed | p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. | 1.77e-05 | 2 | 147 | 2 | 19955483 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23572524 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 32806791 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 31661126 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 32312757 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20053787 | ||
| Pubmed | LKB1 reduces ROS-mediated cell damage via activation of p38. | 1.77e-05 | 2 | 147 | 2 | 25263448 | |
| Pubmed | 2.60e-05 | 14 | 147 | 3 | 26724533 | ||
| Pubmed | 2.60e-05 | 14 | 147 | 3 | 9687510 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 3.13e-05 | 372 | 147 | 9 | 22939624 | |
| Pubmed | Integrin-linked kinase regulates p38 MAPK-dependent cell cycle arrest in ureteric bud development. | 3.98e-05 | 16 | 147 | 3 | 20823064 | |
| Pubmed | 4.41e-05 | 300 | 147 | 8 | 19086053 | ||
| Pubmed | 4.82e-05 | 17 | 147 | 3 | 26542706 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCKAP1 MBOAT7 LMBR1 QRICH1 TAOK2 STXBP3 AP1B1 APH1A NISCH SEC62 NUP133 LSS PRKDC MAPK1 | 4.95e-05 | 942 | 147 | 14 | 31073040 |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 28608568 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 17210568 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 34740862 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12665513 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 18501927 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23560844 | ||
| Pubmed | Significant role for Fas in the pathogenesis of autoimmune diabetes. | 5.31e-05 | 3 | 147 | 2 | 10679090 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 17187070 | ||
| Interaction | MAP2K6 interactions | 1.04e-06 | 74 | 145 | 7 | int:MAP2K6 | |
| GeneFamily | Mitogen-activated protein kinases | 5.36e-07 | 13 | 97 | 4 | 651 | |
| GeneFamily | Fibronectin type III domain containing | 2.34e-06 | 160 | 97 | 8 | 555 | |
| GeneFamily | Abhydrolase domain containing | 5.29e-06 | 22 | 97 | 4 | 4 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.30e-04 | 161 | 97 | 6 | 593 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.79e-04 | 24 | 97 | 3 | 654 | |
| GeneFamily | Solute carriers | SLC24A3 SLC5A2 SLC24A4 SLC28A1 SLC41A1 SLC22A20P SLC4A5 SLC7A10 | 1.29e-03 | 395 | 97 | 8 | 752 |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 1.82e-06 | 200 | 145 | 9 | M6372 | |
| Coexpression | GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 1.82e-06 | 200 | 145 | 9 | M6996 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 1.57e-05 | 199 | 145 | 8 | M3912 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | SOX10 CHRNA6 NAT8B MAK DRD3 DEAF1 HTR1F GAS6 AQP6 SLC5A2 FAT2 MAPK14 NEURL3 MAPK12 APH1A SLC28A1 HAL HCK CNTN2 CNTN1 | 2.70e-05 | 1281 | 145 | 20 | M1884 |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 2.86e-05 | 32 | 145 | 4 | MM17 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 3.66e-05 | 34 | 145 | 4 | M45005 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TBX15 C2orf69 CACUL1 DEAF1 SASH1 NCKAP1 MAN1C1 DOCK10 PIPOX SLC24A3 WSB2 ATP9B AP1B1 STOML1 ASTN2 USP15 MAP4K4 | 4.49e-05 | 1009 | 145 | 17 | M157 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | HAP1 ADGRG1 ADGRL1 SLC24A3 WSB2 TMEM200A SLC5A2 ABHD4 AKTIP MAPK12 CPT1C DDHD1 ASTN1 ASTN2 LSS EPHA3 | 1.39e-05 | 683 | 142 | 16 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | HAP1 ADGRG1 ADGRL1 SLC24A3 WSB2 TMEM200A ALG2 SLC5A2 ABHD4 AKTIP CPT1C DDHD1 ASTN1 ASTN2 LSS EPHA3 | 3.86e-05 | 743 | 142 | 16 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.66e-06 | 185 | 146 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.75e-06 | 186 | 146 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.51e-06 | 193 | 146 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.64e-06 | 194 | 146 | 7 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.64e-06 | 194 | 146 | 7 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-06 | 200 | 146 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 159 | 146 | 6 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| Drug | Calcium | DRD3 MYLK PSEN2 AVPR1A ADGRL1 FASLG F8 ALG2 PASK CACNA2D4 MAPK14 KISS1R KDR TAOK1 MAPK1 USP15 | 1.09e-07 | 493 | 145 | 16 | ctd:D002118 |
| Drug | Ac2-26 | 1.01e-06 | 4 | 145 | 3 | CID000568638 | |
| Drug | NSC-68458 | 1.01e-06 | 4 | 145 | 3 | CID000249771 | |
| Drug | SB202474 | 1.50e-06 | 14 | 145 | 4 | CID000005162 | |
| Drug | serotonin | SOX10 MGAM CHRNA6 DRD3 DEAF1 HTR1F AVPR1A POLR2A TAAR6 GPR161 MAPK14 MAPK12 LHFPL5 MAPK1 MAPK11 | 2.67e-06 | 554 | 145 | 15 | CID000005202 |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; HL60; HT_HG-U133A | 4.98e-06 | 197 | 145 | 9 | 3120_UP | |
| Drug | tolyltriazole | 4.99e-06 | 6 | 145 | 3 | CID000025902 | |
| Drug | piribedil | 6.88e-06 | 42 | 145 | 5 | CID000004850 | |
| Drug | compound 9b | 7.06e-06 | 20 | 145 | 4 | CID000207510 | |
| Drug | n-sulfo-2-aminotricarballylate | 7.06e-06 | 20 | 145 | 4 | CID000135808 | |
| Drug | Cp-38 | 8.69e-06 | 7 | 145 | 3 | CID006918286 | |
| Drug | satratoxin H | 8.69e-06 | 7 | 145 | 3 | CID000434380 | |
| Drug | 2,2',4,6-tetrachlorobiphenyl | 8.69e-06 | 7 | 145 | 3 | CID000044163 | |
| Drug | CID6325568 | 8.69e-06 | 7 | 145 | 3 | CID006325568 | |
| Drug | NSC640330 | 1.34e-05 | 48 | 145 | 5 | CID000005204 | |
| Drug | Z-D-CH2DCB | 1.38e-05 | 8 | 145 | 3 | CID009911778 | |
| Drug | ML3403 | 1.38e-05 | 8 | 145 | 3 | CID006419739 | |
| Drug | VX-745 | 1.80e-05 | 25 | 145 | 4 | CID003038525 | |
| Drug | methyl salicylate | 1.81e-05 | 51 | 145 | 5 | CID000004133 | |
| Drug | SC68376 | 2.07e-05 | 9 | 145 | 3 | CID000005174 | |
| Drug | AMPK inhibitor | 2.26e-05 | 89 | 145 | 6 | CID011524144 | |
| Drug | AC1NOLIT | 2.94e-05 | 10 | 145 | 3 | CID005090286 | |
| Drug | SB220025 | 3.31e-05 | 29 | 145 | 4 | CID000005164 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 3.41e-05 | 193 | 145 | 8 | 5909_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.41e-05 | 193 | 145 | 8 | 3370_UP | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.54e-05 | 194 | 145 | 8 | 4126_DN | |
| Drug | estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | 3.67e-05 | 195 | 145 | 8 | 5910_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.67e-05 | 195 | 145 | 8 | 6698_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.67e-05 | 195 | 145 | 8 | 1045_UP | |
| Drug | Syk inhibitor | 3.71e-05 | 59 | 145 | 5 | CID006419747 | |
| Drug | panobinostat | SOX10 MAK MYLK POLR2A PIPOX IL20RB ADGRG1 SLC24A3 AXIN2 IL1RAPL1 LRRN3 KISS1R SUSD2 ASTN1 ASTN2 KDR MAPK1 SLC7A10 HCK CNTN2 CNTN1 EPHA3 | 3.74e-05 | 1333 | 145 | 22 | ctd:C496932 |
| Drug | L001226 | 3.80e-05 | 30 | 145 | 4 | CID004373102 | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 3.81e-05 | 196 | 145 | 8 | 5230_UP | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 3.81e-05 | 196 | 145 | 8 | 7369_UP | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.95e-05 | 197 | 145 | 8 | 6722_UP | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.95e-05 | 197 | 145 | 8 | 7265_UP | |
| Drug | nemorosone | 4.02e-05 | 11 | 145 | 3 | CID000637105 | |
| Drug | calcium citrate | 4.03e-05 | 2 | 145 | 2 | CID000013136 | |
| Drug | 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE | 4.03e-05 | 2 | 145 | 2 | DB08521 | |
| Drug | SB220025 | 4.03e-05 | 2 | 145 | 2 | DB04338 | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 3237_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 2316_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 6550_UP | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 6089_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 5673_DN | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; PC3; HT_HG-U133A | 4.24e-05 | 199 | 145 | 8 | 6342_DN | |
| Drug | sesamolin | 5.34e-05 | 12 | 145 | 3 | CID000101746 | |
| Drug | MDL-28842 | 5.34e-05 | 12 | 145 | 3 | CID006441200 | |
| Drug | ocaperidone | 5.34e-05 | 12 | 145 | 3 | CID000071351 | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 6.31e-05 | 34 | 145 | 4 | ctd:C569670 | |
| Drug | harmaline | 6.31e-05 | 34 | 145 | 4 | CID000022381 | |
| Drug | BIRB796 | 6.39e-05 | 66 | 145 | 5 | CID000156422 | |
| Drug | lixivaptan | 6.91e-05 | 13 | 145 | 3 | CID000172997 | |
| Drug | MnO2 | 7.03e-05 | 158 | 145 | 7 | CID000014801 | |
| Drug | pyridinyl imidazole | 7.93e-05 | 36 | 145 | 4 | CID000005171 | |
| Drug | AICAR monophosphate | 8.55e-05 | 163 | 145 | 7 | CID000000200 | |
| Drug | SB-242235 | 8.75e-05 | 14 | 145 | 3 | CID009863367 | |
| Drug | CPI-1189 | 8.75e-05 | 14 | 145 | 3 | CID000151118 | |
| Drug | NSC618487 | MYLK PSEN2 MBOAT7 PAK4 PAK6 SLC5A2 TAOK2 CACNA2D4 MAPK14 MAPK12 KDR PRKDC MAPK1 MAPK11 DAGLA HCK EPHA3 | 9.56e-05 | 933 | 145 | 17 | CID000005279 |
| Drug | methyl ethyl ketone | MYLK AVPR1A KEAP1 FASLG TAOK2 AKTIP MAPK14 MAPK12 NISCH KDR MAPK1 MAPK11 HCK | 1.01e-04 | 587 | 145 | 13 | CID000006569 |
| Drug | AC1L1JGQ | 1.04e-04 | 73 | 145 | 5 | CID000005034 | |
| Drug | MMP-2 Inhibitor I | 1.09e-04 | 15 | 145 | 3 | CID000004220 | |
| Drug | NGB 2904 | 1.20e-04 | 3 | 145 | 2 | ctd:C116818 | |
| Drug | Go6983 | 1.21e-04 | 40 | 145 | 4 | CID000003499 | |
| Drug | procymidone | 1.21e-04 | 40 | 145 | 4 | CID000036242 | |
| Drug | 1,2-naphthoquinone | 1.21e-04 | 40 | 145 | 4 | ctd:C040756 | |
| Drug | DB04790 | 1.21e-04 | 40 | 145 | 4 | CID005326924 | |
| Drug | AC1L1BDQ | 1.24e-04 | 173 | 145 | 7 | CID000001394 | |
| Drug | 3 SA | 1.33e-04 | 41 | 145 | 4 | CID000449164 | |
| Drug | SF6847 | 1.33e-04 | 41 | 145 | 4 | CID000005614 | |
| Drug | SD-282 | 1.33e-04 | 16 | 145 | 3 | CID014973220 | |
| Drug | SB 239063 | 1.33e-04 | 16 | 145 | 3 | CID000005166 | |
| Drug | AMP 579 | 1.33e-04 | 16 | 145 | 3 | CID006918429 | |
| Drug | Clorocruoro Hem | 1.39e-04 | 123 | 145 | 6 | CID003518809 | |
| Drug | monomethylarsonous acid | SOX10 MYLK STARD10 GAS6 MAP3K20 ADGRL1 KEAP1 PAK6 TMEM200A MAPK14 DDHD1 SECISBP2 NID1 MAPK1 | 1.45e-04 | 694 | 145 | 14 | ctd:C406082 |
| Drug | 1c88 | 1.58e-04 | 126 | 145 | 6 | CID000444766 | |
| Drug | FSBA | 1.61e-04 | 43 | 145 | 4 | CID000133128 | |
| Drug | Ambotz208527-57-5 | 1.61e-04 | 17 | 145 | 3 | CID010258704 | |
| Drug | dracorhodin | 1.61e-04 | 17 | 145 | 3 | CID000069509 | |
| Drug | kazinol B | 1.61e-04 | 17 | 145 | 3 | CID000480869 | |
| Drug | salinomycin | 1.88e-04 | 185 | 145 | 7 | ctd:C010327 | |
| Drug | olomoucine | 2.04e-04 | 132 | 145 | 6 | CID000004592 | |
| Drug | oleoyl-lysophosphatidic acid | MYLK MBOAT7 MAPK14 MAPK12 DDHD1 SEC62 MAPK1 MAPK11 GPAT4 HCK | 2.10e-04 | 391 | 145 | 10 | CID000003987 |
| Drug | myo-inositol | CHRNA6 MYLK AVPR1A POLR2A AKR1A1 ABHD4 CACNA2D4 MAPK14 KISS1R MAPK12 NISCH MAPK1 MAPK11 DAGLA HCK | 2.14e-04 | 811 | 145 | 15 | CID000000892 |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.21e-04 | 190 | 145 | 7 | 4340_DN | |
| Drug | SB202190 | 2.21e-04 | 134 | 145 | 6 | CID005353940 | |
| Drug | C11102 | 2.25e-04 | 86 | 145 | 5 | CID000443069 | |
| Drug | NK 631 | 2.27e-04 | 19 | 145 | 3 | CID000004741 | |
| Drug | celiprolol | 2.28e-04 | 47 | 145 | 4 | CID000002663 | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.28e-04 | 191 | 145 | 7 | 6022_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.28e-04 | 191 | 145 | 7 | 2850_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.28e-04 | 191 | 145 | 7 | 3905_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.28e-04 | 191 | 145 | 7 | 2937_DN | |
| Drug | bovine serum albumin-corticosterone conjugate | 2.40e-04 | 4 | 145 | 2 | ctd:C439264 | |
| Drug | corticosterone-21-hemisuccinate | 2.40e-04 | 4 | 145 | 2 | ctd:C067957 | |
| Drug | 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol | 2.40e-04 | 4 | 145 | 2 | ctd:C062458 | |
| Drug | DENSPM | 2.47e-04 | 48 | 145 | 4 | CID000004282 | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.51e-04 | 194 | 145 | 7 | 3854_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 2.51e-04 | 194 | 145 | 7 | 3303_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.51e-04 | 194 | 145 | 7 | 5303_UP | |
| Disease | Parkinson's disease (implicated_via_orthology) | DRD3 TOR2A VPS13C PAK4 ATP13A5 PAK6 AXIN2 MAPK14 PTCH2 MAPK11 | 4.63e-09 | 157 | 141 | 10 | DOID:14330 (implicated_via_orthology) |
| Disease | mastiha supplement exposure measurement, blood glutathione peroxidase measurement | 1.06e-06 | 5 | 141 | 3 | EFO_0600067, EFO_0600071 | |
| Disease | Autism Spectrum Disorders | 5.60e-05 | 85 | 141 | 5 | C1510586 | |
| Disease | mitogen-activated protein kinase 12 measurement | 1.35e-04 | 4 | 141 | 2 | EFO_0020576 | |
| Disease | Schizophrenia | SOX10 DRD3 HTR1F PSEN2 AVPR1A AKR1A1 SETDB1 MAPK14 TET1 ASTN2 KDR MAPK1 SLC7A10 | 3.30e-04 | 883 | 141 | 13 | C0036341 |
| Disease | colipase measurement | 3.36e-04 | 6 | 141 | 2 | EFO_0801485 | |
| Disease | MEDULLOBLASTOMA | 3.36e-04 | 6 | 141 | 2 | 155255 | |
| Disease | Medulloblastoma | 3.36e-04 | 6 | 141 | 2 | cv:C0025149 | |
| Disease | Cardiomyopathies, Primary | 3.39e-04 | 69 | 141 | 4 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 3.39e-04 | 69 | 141 | 4 | C0036529 | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 3.56e-04 | 29 | 141 | 3 | DOID:332 (is_marker_for) | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 4.69e-04 | 7 | 141 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | Cholestasis, Extrahepatic | 4.79e-04 | 32 | 141 | 3 | C0005398 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.83e-04 | 206 | 141 | 6 | C0152013 | |
| Disease | Glioma | 7.98e-04 | 9 | 141 | 2 | cv:C0017638 | |
| Disease | Hepatic Insufficiency | 7.98e-04 | 9 | 141 | 2 | C1306571 | |
| Disease | level of Phosphatidylcholine (16:0_22:4) in blood serum | 7.98e-04 | 9 | 141 | 2 | OBA_2045078 | |
| Disease | medulloblastoma (is_implicated_in) | 9.95e-04 | 10 | 141 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | osteoarthritis, knee, body mass index | 9.97e-04 | 41 | 141 | 3 | EFO_0004340, EFO_0004616 | |
| Disease | colonic neoplasm | 9.97e-04 | 41 | 141 | 3 | EFO_0004288 | |
| Disease | high grade glioma (is_marker_for) | 1.07e-03 | 42 | 141 | 3 | DOID:3070 (is_marker_for) | |
| Disease | Gastrointestinal Diseases | 1.45e-03 | 12 | 141 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 1.45e-03 | 12 | 141 | 2 | C0559031 | |
| Disease | Cholera Infantum | 1.45e-03 | 12 | 141 | 2 | C1565321 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 1.45e-03 | 12 | 141 | 2 | OBA_2045157 | |
| Disease | Cardiomyopathy, Dilated | 1.58e-03 | 48 | 141 | 3 | C0007193 | |
| Disease | ascorbic acid 2-sulfate measurement | 1.71e-03 | 13 | 141 | 2 | EFO_0800169 | |
| Disease | Skin Abnormalities | 1.71e-03 | 13 | 141 | 2 | C0037268 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.71e-03 | 13 | 141 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.78e-03 | 50 | 141 | 3 | C1449563 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 1.99e-03 | 14 | 141 | 2 | EFO_0022085 | |
| Disease | pancreatic cancer (is_implicated_in) | 2.08e-03 | 112 | 141 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Metastatic melanoma | 2.22e-03 | 54 | 141 | 3 | C0278883 | |
| Disease | Hepatitis | 2.29e-03 | 15 | 141 | 2 | C0019158 | |
| Disease | Congenital total cataract | 2.60e-03 | 16 | 141 | 2 | C0266539 | |
| Disease | central nervous system disease (implicated_via_orthology) | 2.60e-03 | 16 | 141 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | fasting blood glucose measurement | 2.63e-03 | 287 | 141 | 6 | EFO_0004465 | |
| Disease | post-traumatic stress disorder | 2.92e-03 | 202 | 141 | 5 | EFO_0001358 | |
| Disease | body weight | MGAM C2orf69 CACUL1 HTR1F VPS13C ATP13A5 SNUPN PAK6 AXIN2 ABHD17C BPTF SLC24A4 FNIP1 ASTN2 | 2.93e-03 | 1261 | 141 | 14 | EFO_0004338 |
| Disease | sphingomyelin 14:0 measurement | 2.94e-03 | 17 | 141 | 2 | EFO_0010390 | |
| Disease | lysophosphatidylcholine measurement | 3.29e-03 | 62 | 141 | 3 | EFO_0010224 | |
| Disease | Congenital Fiber Type Disproportion | 3.30e-03 | 18 | 141 | 2 | C0546264 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.33e-03 | 301 | 141 | 6 | DOID:684 (is_marker_for) | |
| Disease | transitional cell carcinoma (is_marker_for) | 3.44e-03 | 63 | 141 | 3 | DOID:2671 (is_marker_for) | |
| Disease | Cardiomyopathies | 3.56e-03 | 130 | 141 | 4 | C0878544 | |
| Disease | Global developmental delay | 3.87e-03 | 133 | 141 | 4 | C0557874 | |
| Disease | myocardial infarction (implicated_via_orthology) | 3.92e-03 | 66 | 141 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 4.27e-03 | 68 | 141 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Deep Vein Thrombosis | 4.49e-03 | 21 | 141 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 4.49e-03 | 21 | 141 | 2 | C0042487 | |
| Disease | Stomach Carcinoma | 4.49e-03 | 21 | 141 | 2 | C0699791 | |
| Disease | hepatitis B (is_marker_for) | 4.49e-03 | 21 | 141 | 2 | DOID:2043 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YRGMELIPTITSWRV | 1101 | Q4VNC0 | |
| VTPYQVRDPMRSWIG | 331 | Q8N8R5 | |
| VMPFSIVYIVRESWI | 76 | P30939 | |
| LGYFSWVMPVSVALS | 311 | Q9NS82 | |
| VLLGSTEYSTPIDMW | 311 | Q07002 | |
| VMPWIPYRTDTLTEY | 176 | O94910 | |
| VQPSYRSALMWFGVI | 96 | Q9H8T0 | |
| ELVVSYPFDMTRTPW | 501 | Q96SM3 | |
| WRLLTPGDYMVTASA | 661 | Q96SM3 | |
| IGFLEGIWPRQSTYM | 376 | Q8WU67 | |
| VPITMIYGSDTWIDT | 281 | Q8TB40 | |
| IWEDETVLPMYEGRI | 821 | Q9Y2T1 | |
| EPEARAAMIWIVGEY | 441 | Q10567 | |
| VGITMIDLYPRDSWN | 171 | Q86W34 | |
| RDLPVMIWIYGGAFL | 116 | P19835 | |
| STLYFIDGMTWPEVL | 316 | Q12830 | |
| IDGMTWPEVLRVYCE | 321 | Q12830 | |
| RIITRFAPMLVPYIW | 41 | O95905 | |
| RFTYTLGEGMWLPLS | 541 | O14525 | |
| EEVRPAGMVWYSILK | 1301 | O75129 | |
| LGRWLVYPGSVSLMT | 106 | Q9H3Z7 | |
| YTLRPEWVQMAPTLF | 291 | Q86Y37 | |
| MVWLVTIIGYTLGIP | 471 | Q8NFF2 | |
| GYVLPSHVTEEMLWE | 596 | Q2TAL8 | |
| AWPEKGMRRVYTTVL | 206 | Q9GZQ6 | |
| GLPTTWGTRYIMVSF | 721 | O60568 | |
| EYVATRWYRAPEIML | 186 | P28482 | |
| MVATREGSIRYWPSL | 176 | Q8WUM0 | |
| EVIIAAWYRTFIGIM | 191 | Q6NXN4 | |
| LQWGEMPTSVAYIRS | 1156 | O95819 | |
| GPELEMWSLGVTLYT | 1181 | Q96RG2 | |
| LVGTPYWMAPEVISR | 561 | Q9NQU5 | |
| GYVATRWYRAPEIML | 181 | Q15759 | |
| EPIGYATDMWSIGVI | 1636 | Q15746 | |
| PEEVIWEALSVMGVY | 216 | P43362 | |
| LPMPIDVVYTWVNGT | 71 | Q3T906 | |
| TELIGRPAMIPYWAL | 1186 | Q2M2H8 | |
| GYVATRWYRAPEIML | 181 | Q16539 | |
| WVILRPGRYICSEMD | 156 | Q8NCI6 | |
| SAWERNLVYPAVMVL | 286 | Q8WVP7 | |
| PIYAVTVSMGLWAFI | 216 | Q96BI3 | |
| TYWAPLGFVLAVTMT | 181 | O43861 | |
| TELIGRPVMVPYWSL | 2126 | O43451 | |
| LVYPDGWDSSEVRRM | 146 | Q8TAF8 | |
| PVIKRTWSSEEMVYP | 4161 | Q9NYQ8 | |
| VMTPNYVVRRGWSIF | 476 | Q9NZN1 | |
| PVEVLTRWMYTVRKG | 541 | P51160 | |
| MVYWTDITEPSIGRA | 991 | P14543 | |
| MLSPTFVLWEVGYPL | 1 | Q6ZU69 | |
| TINMLVRWYVDGPAS | 341 | P48449 | |
| SFWTTMPLVGLGDYV | 161 | Q6U736 | |
| MSVDRWYVTVFPLRA | 136 | Q969F8 | |
| MSPEEWTYLVVLLIS | 1 | Q96N66 | |
| MGVYAPTLLIVVLSW | 271 | P48167 | |
| SVYWHVIGMGTTPEV | 271 | P00451 | |
| WMVTIIGYTLGIPDV | 496 | Q9HC58 | |
| LLMWSPVIAPGETVY | 51 | Q6UXL0 | |
| YVPNMVVWEHTFTPR | 691 | Q9Y2A7 | |
| AYIQPWRFRVEMIKG | 66 | Q8IYK2 | |
| WEEFVYLRSRNPLMV | 236 | Q8TCG5 | |
| RWDPMEYDGIETLRV | 96 | Q15825 | |
| WSFGILLMEIVTYGR | 441 | P08631 | |
| MPRYTVHVRGEWLAV | 1 | P42357 | |
| EALETSVGYAWLPLM | 781 | Q96BY6 | |
| IVCSVWYLPPMTREA | 381 | Q86UL3 | |
| LYVFFGVGSVMRWPT | 36 | Q13520 | |
| ELSEPRSWLYLEEMV | 446 | O75398 | |
| TDEWIYIESPITMIG | 296 | Q86XK2 | |
| VVTAPMEAYWTALAL | 731 | Q7Z3S7 | |
| NLYTMPRIGEPVWLT | 406 | Q8TF40 | |
| LERIFWIPIVREYVM | 141 | Q6ZPD8 | |
| DYMRTPLDVGTESTW | 491 | Q14393 | |
| PPVWESVTYGMVLQR | 186 | P54257 | |
| LIPWMEYEFRVVATN | 671 | Q12860 | |
| AMYERCPRAVEPLWV | 286 | Q6PCB6 | |
| RTPEGVIYPSMCWIR | 551 | Q9Y653 | |
| QVLGLTPWMDYEFRV | 671 | Q02246 | |
| IRVESGCWMIYERPN | 36 | P07316 | |
| GIVLWEVMSYGERPY | 811 | P29320 | |
| LIFDLGDPVRWEYML | 361 | Q8IY82 | |
| LIRAVTWMDNPIEVY | 111 | P61565 | |
| VYSSPIDVWAVGSIM | 176 | P20794 | |
| SYGVVLWEMLTREVP | 191 | Q9NYL2 | |
| LRPEVVESYMYLWRQ | 521 | Q9NR34 | |
| IIWLSMRGGILYTEP | 76 | Q9Y4D2 | |
| EWYPSLATMQESLRV | 91 | Q8TAE8 | |
| VTWGPYMVVIASEAL | 281 | Q8N6U8 | |
| RYDVETETWTFVAPM | 536 | Q14145 | |
| VITYDIMTGWNPVRL | 541 | Q8NEL9 | |
| PTSWVYLTAAVMERL | 306 | A6NKP2 | |
| MAVSVPWYLGLAFRT | 1781 | Q9NYQ7 | |
| WVYNRSVFPSTIVME | 111 | A6NK97 | |
| YMREVTTIDPRWLVE | 1161 | Q14562 | |
| LVMPWVVYLEVTGGV | 81 | P35462 | |
| VGTPYWMAPELISRL | 476 | O96013 | |
| GTNYLMPWDIVIRTR | 791 | Q8ND04 | |
| PMLGITGSERDYQLW | 231 | Q9P2F6 | |
| TITIELWGYEETGMP | 191 | Q9UGT4 | |
| ITLRSWLPMGADYII | 131 | Q9Y365 | |
| MEVLRPFLGSSWVVY | 171 | Q8N2E6 | |
| GVTVVAFMISWLPYS | 261 | Q96RI8 | |
| ISIIGIAMAVLGYWP | 71 | Q86VY9 | |
| EIRPWFTPRSIYMEA | 36 | Q9H3W5 | |
| IPPELFYMGLTVWVS | 851 | Q9Y6C5 | |
| METYAFWRPPVRTLT | 316 | Q96SF7 | |
| CTRELSWTPMGYVVR | 291 | Q96T21 | |
| SFVGTPYWMAPEVIL | 181 | Q7L7X3 | |
| SFVGTPYWMAPEVIL | 181 | Q9UL54 | |
| LYSGWEPVIIAMAIS | 316 | Q8IVJ1 | |
| PRSEFEEMTILYDIW | 1671 | Q9UPS6 | |
| RWRSMTVVPYLEDLH | 331 | Q15831 | |
| TPLVGWLRPYMVSDV | 271 | O95149 | |
| WLRPYMVSDVLGVAV | 276 | O95149 | |
| SDMIRNWSYLGVPIV | 436 | O00186 | |
| EWIYRGSTRLEPMFS | 386 | Q15047 | |
| VWDGIPLPMADRLYT | 1521 | Q8NFU7 | |
| WRYIVPMLTVDGKRV | 296 | P14550 | |
| RAPIDWIEEYTTGMA | 156 | Q9H553 | |
| MEVLRPFLGSSWVVY | 171 | Q5JU69 | |
| AIVPLWASMGNYITR | 171 | Q9H1C4 | |
| VLYPVASMRHLELWV | 521 | Q13496 | |
| TLFPLWPAEMRVGVY | 211 | Q99442 | |
| WLFAPVYLTAGVITM | 111 | P31639 | |
| WFALKIVPTYERMIV | 76 | Q9UBI4 | |
| VLARAPVMDTWFYIT | 141 | Q56A73 | |
| RYARPEWMIVTVLPV | 241 | P24928 | |
| ILEWHYVVRGPEMTP | 41 | Q8N2K1 | |
| LMWSSVVFYQTPGLE | 1161 | Q9Y2I1 | |
| SGYDWTLVPMPVRVN | 81 | P56693 | |
| TMEERSWGPYITCIQ | 376 | P20061 | |
| VSWYTLMEGQEPIAR | 101 | Q9Y4E8 | |
| EPIFPALIYSSAMVW | 286 | P49810 | |
| SVSDWLISIGLPMYA | 1181 | O94885 | |
| FMGLPWYVAATVISI | 886 | Q9BY07 | |
| GSRMVLSVFSPYWLI | 2761 | Q709C8 | |
| AVVGSPYWMAPEVLR | 216 | Q15569 | |
| YILRPVAFLMGVAWE | 466 | O00337 | |
| RSMPLEWEDTYGIVL | 156 | P48023 | |
| YVTWMTGGIFVAPVV | 216 | P37288 | |
| VGAPLWAVMDVYGTT | 151 | Q96EH8 | |
| YSVVPMTSRLGLIEW | 3791 | P78527 | |
| AWYSVGALMISVPAL | 91 | Q5T4F4 | |
| TLRINVCYWREMVPG | 221 | Q9P0Z9 | |
| WMAPETIFDRVYTIQ | 1071 | P35968 | |
| TNVIMWDPYTGERLR | 261 | Q9NYS7 | |
| IYSVRVGSPWIDQMT | 161 | Q9UI38 | |
| WEPTILPNGYMFSRI | 1346 | Q5VZL5 | |
| WVEVMRAATFTYSPL | 51 | Q6PEX7 | |
| IGYLQFRLVELVWMP | 246 | Q8NBV4 | |
| FMPDPSSEWLYRVTV | 251 | Q9H6D3 | |
| EMTGYVVTRWYRAPE | 181 | P53778 | |
| PWTRYVDIALRTDMS | 81 | Q9UHF3 | |
| RELYIRWLEVAAFMP | 571 | Q6NSJ0 |